Pneumococcal vaccine (Prevnar) for otitis media.
D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004890:Erythema / Q000139:chemically induced; D005252:Fees, Pharmaceutical; D000069443:Heptavalent Pneumococcal Conjugate Vaccine; D006801:Humans; D007223:Infant; D022401:Meningococcal Vaccines / Q000009:adverse effects / Q000600:supply & distribution / Q000627:therapeutic use*; D010033:Otitis Media / Q000517:prevention & control*; D022242:Pneumococcal Vaccines / Q000009:adverse effects / Q000600:supply & distribution / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D014611:Vaccination / Q000009:adverse effects / Q000191:economics
D000069443:Heptavalent Pneumococcal Conjugate Vaccine; D022401:Meningococcal Vaccines; D022242:Pneumococcal Vaccines